CD276 and familial pancreatic carcinoma: In contrast, most previously published studies on B7-H3 expression in pancreatic cancer do not show any data on validation of their B7-H3 immunohistochemistry protocol (24, 36–38, 40–42), and/or do not even mention the anti-B7-H3 antibody clone used (37, 40, 42).